OMX Nordic 40
|
2 640,23
|
43,62
|
1,68 %
|
Analysen zu OMX Nordic 40-Werten
| 26.03.26 | ABB Neutral | JP Morgan Chase & Co. | |
| 26.03.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 26.03.26 | Novo Nordisk Hold | Deutsche Bank AG | |
| 26.03.26 | Hennes & Mauritz AB Underweight | Barclays Capital | |
| 26.03.26 | Volvo AB Buy | Goldman Sachs Group Inc. | |
| 26.03.26 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 26.03.26 | ABB Market-Perform | Bernstein Research | |
| 26.03.26 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
| 26.03.26 | Nokia Buy | Jefferies & Company Inc. | |
| 25.03.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 24.03.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 24.03.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 23.03.26 | Volvo AB Sector Perform | RBC Capital Markets | |
| 23.03.26 | ABB Sector Perform | RBC Capital Markets | |
| 20.03.26 | Volvo AB Buy | Jefferies & Company Inc. | |
| 19.03.26 | ABB Sector Perform | RBC Capital Markets | |
| 16.03.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.03.26 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.03.26 | Volvo AB Market-Perform | Bernstein Research | |
| 09.03.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 06.03.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 06.03.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 06.03.26 | A.P. Moeller - Maersk A-S Equal Weight | Barclays Capital | |
| 05.03.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 03.03.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 03.03.26 | Hennes & Mauritz AB Neutral | UBS AG | |
| 02.03.26 | A.P. Moeller - Maersk A-S Underweight | Barclays Capital | |
| 02.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.03.26 | Novo Nordisk Neutral | Goldman Sachs Group Inc. | |
| 27.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 26.02.26 | AstraZeneca Buy | UBS AG | |
| 25.02.26 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 24.02.26 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
| 24.02.26 | Volvo AB Market-Perform | Bernstein Research | |
| 24.02.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 24.02.26 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 24.02.26 | Hennes & Mauritz AB Underweight | Barclays Capital | |
| 24.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 24.02.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 23.02.26 | Novo Nordisk Hold | Deutsche Bank AG |